Read UMR's July 13 Statement on NIH Funding in House Labor-HHS Appropriations Bill
NIH Research 101 | UMR Answers Common Questions About NIH Research in this New Fact Sheet Series
NIH's Role In Sustaining the U.S. Economy | 2023 Update Now Available
Why Invest in NIH Research? | UMR Offers Fact Sheets Explaining Why Congress Must #keepNIHstrong

A participant in the NIH 2019-2020 Medical Research Scholars Program.

Photo Credit: National Institutes of Health

About This Photo

Nearly all severely allergic people tolerate COVID-19 vaccines, study finds

While individuals with severe allergies reported more reactions after receiving a COVID-19 mRNA vaccine than those without allergies, nearly all were able to safely complete the series, according to an Oct. 27 study in JAMA Network Open. Researchers at Boston-based Mass General Brigham and Harvard Medical School used electronic health records of 52,998 employees, of whom 97.6 percent received both doses of vaccine, and 0.9 percent reported a history of high-risk allergy.